Shattuck Labs (STTK) Income from Non-Controlling Interests (2023 - 2026)
Shattuck Labs' (STTK) quarterly Income from Non-Controlling Interests came in at -$6000.0 in Q1 2026, down 200.0% year-on-year from $6000.0 in Q1 2025, and down 300.0% on a QoQ basis from $3000.0 in Q4 2025.
Shattuck Labs (STTK) Income from Non-Controlling Interests (2023 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 4 years of Income from Non-Controlling Interests data on file, last reported at -$6000.0 in Q1 2026.
- On a quarterly basis, Income from Non-Controlling Interests fell 200.0% year-over-year to -$6000.0 in Q1 2026; TTM through Dec 2025 was $4000.0, a 300.0% increase from a year earlier, with the FY2025 full-year figure at $4000.0, up 300.0% from the prior year.
- Income from Non-Controlling Interests for Q1 2026 stood at -$6000.0, down from $3000.0 in the prior quarter.
- Over the last five years, Income from Non-Controlling Interests for STTK reached as high as $538000.0 in Q1 2023 and fell as low as -$50000.0 in Q4 2024.
- Historically, Income from Non-Controlling Interests has averaged $67461.5 across 4 years, with a median of $2000.0 in 2025.
- Across the five-year window, Income from Non-Controlling Interests plunged 1566.67% in 2024 and surged 106.0% in 2025, its largest moves.
- Year by year, Income from Non-Controlling Interests stood at -$3000.0 in 2023, then sank by 1566.67% to -$50000.0 in 2024, then jumped by 106.0% to $3000.0 in 2025, then slumped by 300.0% to -$6000.0 in 2026.
- Per Business Quant data, the three most recent Income from Non-Controlling Interests figures were -$6000.0 in Q1 2026, $3000.0 in Q4 2025, and $2000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Shattuck Labs | 795.74 Mn | 795.74 Mn | - | -6,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Mar 31, 2025 | -2,000.00 |
| Dec 31, 2024 | -50,000.00 |
| Sep 30, 2024 | 57,000.00 |
| Jun 30, 2024 | 9,000.00 |
| Mar 31, 2024 | -18,000.00 |
| Dec 31, 2023 | -3,000.00 |
| Sep 30, 2023 | 81,000.00 |
| Jun 30, 2023 | 265,000.00 |
| Mar 31, 2023 | 538,000.00 |